AlphaCentric Advisors LLC

SEC CIK: 0001913464
Latest filing: Jul 24, 2026

SEC filings (opens in a new tab)

TRML holding history

Tourmaline Bio, Inc. in every 13F filed by AlphaCentric Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TRML overview All 13F holders of TRML Full Q2 2026 holdings

Shares (Q4 2024): 0; Sold out in Q4 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2024

Holdings of TRML by AlphaCentric Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2024	0	$0	0.0%	−5,500−100.0%	Sold out	Holders
Q3 2024	5,500	$141.4K	0.1%	−69,500−92.7%	Reduced	Holders
Q2 2024	75,000	$964.5K	0.7%	+13,900+22.7%	Added	Holders
Q1 2024	61,100	$1.40M	0.8%	+61,100	New	Holders